Antimalarials should target female parasites

Disease causing organisms are notorious for their rapid evolution and their quick aquisition of resistance to the drugs used to fight them. However, in the case of the disease causing parasites Plasmodium, scientists have shown that it is the males of the species that really race ahead in the evolutionary race.

Sex is a key driver for evolution but this tends to be overlooked when looking at unicellular life forms, said Sarah Reece of Edinburgh University and her colleagues in their paper. The Plasmodium parasite, unlike humans, for example, does not have different genes coding for different sexes. Instead, sex is solely determined by which genes are expressed. Reece and colleagues placed the parasites under evolutionary pressure and observed that it was the male-biased genes that were the fast adaptors. The finding suggests that to help prevent resistance, new antimalarials should target the slower evolving female genes, or those that are expressed by both sexes.


Related Content

New antimalarial drug class resists resistance

21 March 2013 Research

news image

Drug candidate looks promising as scientists draw on past failures to address toxicity problems

Malaria no more?

26 March 2008 Feature

news image

Has malaria finally met its scientific match? Victoria Gill finds out whether a fresh round of research funding could put an ...

Most Read

Lab-on-a-chip rises to cola challenge

13 May 2013 Research

news image

'Liquid fingerprinting' can 'taste' the difference between red wines, mineral waters and vodkas

Sugar solution to toxic gold recovery

15 May 2013 Research

news image

The environmental legacy of salvaging gold from electronic waste can be dramatically cut using corn starch instead of cyanide

Most Commented

Congress says US needs a science laureate

14 May 2013 News and Analysis

news image

New legislation proposes the appointment of a public champion for research

US moves in different direction on pesticides

7 May 2013 News and Analysis

news image

While the EU is zeroing in on neonicotinoids as a major cause of bee deaths, the US is looking elsewhere